Replies to post #124457 on PharmaCyte Biotech Inc (PMCB)

[livendi]

yes, pmcb owns like 14% of austrianova,a lot of good its done us,

[$Pistol Pete$]

Austrianova has zero dollars revenue and always fund by this scam company to survive and sustain. This scam company own 14.5% and if it is ever success, there is not much left for shareholders.

[oldmusky]

Austrianova is run by a group of scientists and they manufacture Ciab. PharmaCyte not only owns 14.5% of Austrianova but also owns the rights to many of Ciab's uses, including Pancreatic Cancer.

[DragonBear]

Pharmacyte versus Austrianova

Once upon a time...Salmons&Ginzburg working out of the academic world of Austria came up with the idea of the CIAB. With patent filed, they then started up Austrianova (AN). That apparently occurred mid-late 1990s. Unable to raise capital. Skipping past their bankruptcy in 2005, what was Salmons&Gunzburg to do? How to make money off of their idea? With AN's credit not so good. On 25-Jun-2013 they grant a license to Nuvilex Inc (predecessor to PMCB in name only). In return, AN received $2M for the licensing, and another $650K "a one-time Manufacturing Setup". Then there were the Addendums...

The Third Addendum provided that the Company acquire 100% of the equity interests in Bio Blue Bird and receive a 14.5% equity interest in SG Austria. In addition, the Company received nine bearer shares of Bio Blue Bird to evidence its 100% ownership. Under the Third Addendum, the Company paid: (i) $500,000 to retire all outstanding debt of Bio Blue Bird; and (ii) $1.0 million to SG Austria. The Company also paid SG Austria $1,572,193 in exchange for its 14.5% equity interest. The Third Addendum returned the original 100,000,000 shares of common stock held by SG Austria to the Company treasury, and the 100,000 Austrianova shares of common stock held by the Company were returned to SG Austria.

Basically PMCB has been AN's ATM machine. They used the funds to setup their Thai 2 room production facility. With PMCB essentially locked in to using AN to manufacture CIABs. Initially Gunzburg was appointed chief science officer, and later gave way (the SEC did question the conflict of interest), where PMCB hired Salmons&Gunzburg's consulting firm. So those two make money on the side as consultants. In any case, as the founders of AN, they have made money.

You'll hear a lot of cheers about the 14% ownership of AN. As you can see above it wasn't for free. So what is AN worth? A company which has relied on PMCB for funding. A company whose only known sales are selling do it yourself CIAB kits thru Sigma. They did go on to invent Bac-in-a-box which is a bit different than CIAB. It also has no known market.

Per the license PMCB paid $Ms for is sitting on top of an expired CIAB patent -expired 2017. Kenny tried to file a new patent for the same use, and rightly got rejected by the USPO. In the meantime, AN picked up a few more coins when running 6 different manufacturing runs in 2018-2019. With only the last 2 successfully completed.

So there's the history and relationship between the 2 companies. PMCB is an ATM machine for AN. And yes, all the transactions were legal, PMCB SHs paying for it.